European Conference on Rare Diseases 2026 : Rare Diseases in a Changing & Competitive Europe
La 13e Conférence Européenne sur les Maladies Rares (ECRD) se tiendra du 2 au 4 juin 2026 à Prague. Cet événement piloté par les patients réunit malades, défenseurs, décideurs, cliniciens et industriels pour façonner les politiques de demain.
Avec plus de 700 participants en 2024, l’ECRD est le plus grand événement européen sur les maladies rares, une occasion unique d’échanger et d’influencer les politiques.
De 13de Europese Conferentie over Zeldzame Ziekten (ECRD) vindt plaats van 2 tot 4 juni 2026 in Praag. Dit door patiënten geleide evenement brengt mensen met zeldzame ziekten, pleitbezorgers, beleidsmakers, clinici en industrie samen om toekomstige beleidslijnen vorm te geven.
Met meer dan 700 deelnemers in 2024 is ECRD Europa’s grootste zeldzame ziekten evenement, een unieke kans om te netwerken en impactvolle aanbevelingen te formuleren.
European Conference on Rare Diseases 2026 : Rare Diseases in a Changing & Competitive Europe
The 13th European Conference on Rare Diseases & Orphan Products (ECRD) will take place from 2 to 4 June 2026 in Prague under the theme “Rare Diseases in a Changing & Competitive Europe: Shaping policies to address the unmet needs of people living with rare diseases.”
As the largest patient-led rare disease policy event in Europe, the ECRD brings together a diverse community including people living with rare diseases, patient advocates, policymakers, healthcare industry representatives, clinicians, regulators, and Member State officials. This broad coalition empowers EURORDIS to drive goal-oriented policies that directly address the unmet needs of the rare disease community.
Building on the success of the 12th ECRD in 2024—which gathered over 700 participants both online and onsite in Brussels—ECRD 2026 will continue to offer an unparalleled platform for networking, knowledge exchange, and collaboration. These discussions culminate in clear policy recommendations designed to influence EU and national legislation, ensuring the rare disease community’s voice is heard loud and clear.
Whether you are a patient, healthcare professional, policymaker, or industry expert, ECRD 2026 is your opportunity to engage with key stakeholders shaping the future of rare disease policy in Europe.